IKAROS and MENIN in synergy in AML.
Jones, LQ M; Starczynowski, DT.
2022;
3:528-529.
Targeted Therapy in Pediatric AML: An Evolving Landscape.
Jones, LM; Tarlock, K; Cooper, T.
Paediatric Drugs.
2021;
23:485-497.
Effect of osteopathic manipulative treatment on pulmonary function testing in children with asthma.
Jones, LM; Regan, C; Wolf, K; Bryant, J; Rakowsky, A; Pe, M; Snyder, DA.
The Journal of the American Osteopathic Association.
2021;
121:589-596.
Methylation profiling of hypomethylating agent response and treatment failure in pediatric and young adult MDS/AML.
Jones, LM; O'Brien, MM; Breese, EH; Absalon, M; Burns, KC; Grimley, M; Mizukawa, B; Lee, LH; Perentesis, JP; Phillips, CL.
Journal of Clinical Oncology.
2020;
38:e22502-e22502.
Targeting AML-associated FLT3 mutations with a type I kinase inhibitor.
Jones, LM; Melgar, K; Bolanos, L; Hueneman, K; Walker, MM; Jiang, J; Wilson, KM; Zhang, X; Shen, J; Jiang, F; et al.
Journal of Clinical Investigation.
2020;
130:2017-2023.
Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response Pathways.
Melgar, KM; Jones, LM; Walker, M; Bolanos, LC; Hueneman, K; Wunderlich, M; Jiang, J; Wilson, K; Zhang, X; Sutter, P; et al.
Blood.
2019;
134:3934-3934.
Overcoming adaptive therapy resistance in AML by targeting immune response pathways.
Melgar, K; Walker, MM; Jones, LM; Bolanos, LC; Hueneman, K; Wunderlich, M; Jiang, J; Wilson, KM; Zhang, X; Sutter, P; et al.
Science Translational Medicine.
2019;
11.
Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient.
Jones, L; Dandoy, C; Jodele, S; Myers, KC; Luchtman-Jones, L; Quinn, CT; Mullins, E; El-Bietar, J.
Bone Marrow Transplantation.
2018;
53:487-489.
Patterns of Emergency Department Care for Newly Diagnosed Immune Thrombocytopenia in United States Children's Hospitals.
Jones, L; Koch, T; Stanek, J; O'Brien, SH.
Journal of Pediatrics.
2017;
190:265-267.